Observed in a single European patient, a 3836 base DUP directly impacts exon 4 of SLC2A5 (Supplementary Fig. 11), which downregulated in PCa (p-value < 0.001, GENT2 T-test) and has been identified as an oncogenic behaviour (Supplementary Table 7), therefore allocated PP-SV status. Here, SLC2A5 is linked to posterior cortical atrophy.